Lipids, lipid compositions, and methods of using them

Details for Australian Patent Application No. 2010334911 (hide)

Owner Novartis AG

Inventors Baryza, Jeremy; Bowman, Keith; Geall, Andrew; Labonte, Tanzina; Lee, Cameron; Vargeese, Chandra; West, Laura; Zhao, Junping

Agent Davies Collison Cave

Pub. Number AU-A-2010334911

PCT Pub. Number WO2011/076807

Priority 61/284,787 23.12.09 US

Filing date 21 December 2010

Wipo publication date 30 June 2011

International Classifications

A61K 9/127 Medicinal preparations characterised by special physical form - Liposomes

A61K 9/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61K 47/18 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/28 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Steroids

A61K 47/30 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61P 1/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 35/00 Antineoplastic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/076807 Priority application(s): WO2011/076807

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010334915-Carboxamide compounds and their use as calpain inhibitors

2010334908-Method for determining the liver function of a human being by quantitatively measuring the metabolism of substrates